טוען...

Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics

To move forward with immunotherapy it is important to understand how the tumor microenvironment generates systemic immunosuppression in patients with renal cell carcinoma (RCC) as well as in patients with other types of solid tumors. Even though antigen discovery in RCC has lagged behind melanoma, r...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Finke, James H, Rayman, Pat A, Ko, Jennifer S, Bradley, Judy M., Gendler, Sandra J, Cohen, Peter A
פורמט: Artigo
שפה:Inglês
יצא לאור: 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3879112/
https://ncbi.nlm.nih.gov/pubmed/23867518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31829da0ae
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!